RJ Quick
Drive Therapeutics awarded a Phase 1 SBIR from the NSF
Drive was recently awarded a $256,000 Phase 1 SBIR grant from the NSF to help continue development of our novel, aptamer based inhibitors...
top of page
Search
RJ Quick
Feb 5, 20211 min read
Drive Receives Funding from NC Biotech Center
Drive Therapeutics of Research Triangle Park received $100,000 to develop a novel nucleic acid therapy to block angiogenesis,...
137 views1 comment
RJ Quick
Jul 9, 20202 min read
Welcome Doug Gooding to the Drive Therapeutics Team!
Doug has agreed to join the team as CEO and help us navigate fundraising, early stage company formation, and relationship formation...
359 views0 comments
RJ Quick
Apr 23, 20201 min read
Go Aptamers Go!!
Exciting news out of the University of Louisville.....
107 views0 comments
RJ Quick
Apr 20, 20201 min read
Catch Up With Us on Gust
As a fledgling biotech startup, we are looking for ways to raise funding and meet potential investors while #stayingathome. We have...
61 views0 comments
Blog: Blog2
bottom of page